Description

3,5-Dimethyl-9,9-Dioxo-8-Phenacyl-9$L^{6}-Thia-2,8-Diazabicyclo[4.3.0] Nona-2,4,10-Trien-7-One is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily required by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and specialty fine chemical industries for creating new compounds with targeted biological activity.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, especially those with complex bicyclic or tricyclic frameworks.
• Agrochemical Research: Used in the development of new pesticides and herbicides, where its unique structure can contribute to novel modes of action.
• Organic Synthesis Building Block: Employed in academic and industrial research laboratories for constructing complex heterocyclic molecules for material science or catalysis studies.
• Process Chemistry & Scale-Up: Utilized in optimizing synthetic routes from milligram to kilogram scale for clinical trial material production.
• Custom Synthesis & Contract Manufacturing: A key starting material for CDMOs (Contract Development and Manufacturing Organizations) offering bespoke chemical synthesis services.

Basic Information

Product Name	3,5-Dimethyl-9,9-Dioxo-8-Phenacyl-9$L^{6}-Thia-2,8-Diazabicyclo[4.3.0] Nona-2,4,10-Trien-7-One
CAS No.	108361-85-9
Molecular Formula	C19H16N2O4S
Molecular Weight	368.41 g/mol
Synonyms	8-Phenacyl-3,5-dimethyl-9,9-dioxo-9λ⁶-thia-2,8-diazabicyclo[4.3.0]nona-2,4,10-trien-7-one; 3,5-Dimethyl-8-phenacyl-9,9-dioxo-9-thia-2,8-diazabicyclo[4.3.0]nona-2,4,10-trien-7-one; Bicyclo[4.3.0]nona-2,4,10-triene derivative; 9λ⁶-Thia-2,8-diazabicyclo[4.3.0]nona-2,4,10-trien-7-one, 3,5-dimethyl-9,9-dioxo-8-phenacyl-; CAS 108361-85-9
EINECS	Contact for details

Quality Control

Our production of 3,5-Dimethyl-9,9-Dioxo-8-Phenacyl-9$L^{6}-Thia-2,8-Diazabicyclo[4.3.0] Nona-2,4,10-Trien-7-One adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and/or moisture-sensitive; prolonged exposure to light, heat, or humidity should be avoided to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Impurity	≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.